These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18723823)

  • 1. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
    Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
    Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
    Chan KW; Wheeler A; Csanády L
    J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
    Li CG; Cui WY; Wang H
    Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
    López-Alonso JP; de Araujo ED; Kanelis V
    Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
    Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
    J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
    Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
    J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly limits the pharmacological complexity of ATP-sensitive potassium channels.
    Giblin JP; Cui Y; Clapp LH; Tinker A
    J Biol Chem; 2002 Apr; 277(16):13717-23. PubMed ID: 11825905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
    Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
    Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
    Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
    D'hahan N; Jacquet H; Moreau C; Catty P; Vivaudou M
    Mol Pharmacol; 1999 Aug; 56(2):308-15. PubMed ID: 10419549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers.
    Adebiyi A; McNally EM; Jaggar JH
    Mol Pharmacol; 2008 Sep; 74(3):736-43. PubMed ID: 18511652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.